125 results
Page 2 of 7
8-K
EX-1.1
xk5 2uxyp
12 May 22
Entry into a Material Definitive Agreement
8:31am
424B5
18wv4qh1zjpyws
12 May 22
Prospectus supplement for primary offering
8:30am
424B3
600rwl1381w
27 Dec 21
Prospectus supplement
5:01pm
8-K
EX-10.1
m9suf4mayqpayl3 4c68
24 Nov 21
Entry into a Material Definitive Agreement
7:27am
8-K
EX-1.1
hti482dfik 16kc2g8
21 May 21
Seelos Therapeutics Announces Pricing of $60 Million Public Offering of Common Stock
12:00am
424B5
ok2 59bxsqg0d0ihy7
21 May 21
Prospectus supplement for primary offering
12:00am
424B5
vb8vop2c 8iikup
19 May 21
Prospectus supplement for primary offering
4:08pm
424B5
7xf7jijt1i8y
26 Jan 21
Prospectus supplement for primary offering
5:11pm
424B5
bshfls2gp0jin6s5i vx
25 Jan 21
Prospectus supplement for primary offering
4:16pm
8-K
EX-10.1
rmufpav
17 Dec 20
Entry into a Material Definitive Agreement
4:05pm